Solasia Pharma K.K. Announces New Executive Leadership, Clinical Activities, and China Operations

Published: Feb 06, 2013

Solasia Pharma K.K. announced today a change in its executive leadership team. Yoshihiro Arai, currently General Manager and Head of Development of Solasia Pharma K.K., has been promoted to President and Representative Director of the company. Current Chief Executive Officer Steve Engen has announced his departure to pursue a new career opportunity.

Back to news